Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Author: Prasad Ravindranath

Science Editor with @The_Hindu, Chennai, India. Do get in touch with me at PRASAD.THEHINDU@GMAIL.COM if you have some interesting results that can be published in The Hindu and also in my blog. You can also reach me on Twitter @RPrasad12 and Facebook /prasad.ravindranath. I write on science, health, medicine, environment, and technology.
Posted on January 28, 2021January 28, 2021

With more vaccines than vaccinations, India exports Covishield before expiry date

It is true that while the U.S. took 10 days to breach the one-million mark and the U.K. took 18 days, India took only six days. The number of people…

Continue Reading
Posted on January 27, 2021January 27, 2021

Study finds Covaxin effective against the UK variant

The sera from people vaccinated with Covaxin were tested against the same strain used for making the vaccine, another strain found in India but different from the one used for…

Continue Reading
Posted on January 23, 2021January 23, 2021

Glitches in CoWIN also responsible for low COVID-19 vaccine uptake

On January 16, the first day of COVID-19 vaccination in the country, at about only 1.91 lakh health-care workers taking the jab, only about two-third of the eligible people were…

Continue Reading
Posted on January 15, 2021January 15, 2021

Indian scientists divided over restricted use approval for Covaxin

In a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the Indian regulator are safe. The Health Ministry released a statement…

Continue Reading
Posted on January 15, 2021January 15, 2021

Vaccine dilemma: To take or not to take Covaxin

True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…

Continue Reading
Posted on January 13, 2021

Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial

The phase-3 clinical trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, by a private hospital in the Bhopal-based Peoples College of Medical Sciences & Research Centre appears to suffer from serious…

Continue Reading
Posted on January 9, 2021January 9, 2021

New challenges in conducting COVID-19 vaccine trials in India

The Ahmedabad-based Zydus Cadilla only recently got the regulatory permission to carry out phase-3 trial and has to begin the recruitment, while the Hyderabad-based Biological E is yet to reach…

Continue Reading
Posted on January 8, 2021

I would not take Covaxin without efficacy data: Gagandeep Kang

Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use. Three safe and efficacious vaccines from Pfizer, Moderna and AstraZeneca…

Continue Reading

Posts navigation

Page 1 Page 2 … Page 242 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,595 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • With more vaccines than vaccinations, India exports Covishield before expiry date January 28, 2021
  • Study finds Covaxin effective against the UK variant January 27, 2021
  • Glitches in CoWIN also responsible for low COVID-19 vaccine uptake January 23, 2021
  • Indian scientists divided over restricted use approval for Covaxin January 15, 2021
  • Vaccine dilemma: To take or not to take Covaxin January 15, 2021

Most Read Posts

  • Study finds Covaxin effective against the UK variant
  • With more vaccines than vaccinations, India exports Covishield before expiry date
  • No correlation between Ct values of PCR test and COVID-19 severity
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • Can we rely on natural herd immunity to end COVID-19 pandemic?
  • I would not take Covaxin without efficacy data: Gagandeep Kang
  • Vaccine dilemma: To take or not to take Covaxin
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,595 other followers

Archives

Cancel